These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24157294)

  • 1. Comments on reducing the health consequences of opioid addiction.
    Keller DL
    Am J Med; 2013 Nov; 126(11):e19. PubMed ID: 24157294
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening and brief intervention for opioid addiction in primary care is not evidence based.
    Saitz R
    Am J Med; 2013 Nov; 126(11):e15. PubMed ID: 24157292
    [No Abstract]   [Full Text] [Related]  

  • 3. The reply.
    Bruce RD; Beletsky L; Stancliff S
    Am J Med; 2013 Nov; 126(11):e17. PubMed ID: 24157293
    [No Abstract]   [Full Text] [Related]  

  • 4. The reply.
    Bruce RD; Beletsky L; Stancliff S; Bowman S
    Am J Med; 2013 Nov; 126(11):e21-2. PubMed ID: 24157295
    [No Abstract]   [Full Text] [Related]  

  • 5. Reducing the health consequences of opioid addiction in primary care.
    Bowman S; Eiserman J; Beletsky L; Stancliff S; Bruce RD
    Am J Med; 2013 Jul; 126(7):565-71. PubMed ID: 23664112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine Spiking in a Pain Medicine Clinic: An Attempt to Simulate Adherence.
    Lee D; Bazydlo LA; Reisfield GM; Goldberger BA
    Pain Med; 2015 Jul; 16(7):1449-51. PubMed ID: 25522892
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of Opioid Overdose.
    Babu KM; Brent J; Juurlink DN
    N Engl J Med; 2019 Jun; 380(23):2246-2255. PubMed ID: 31167053
    [No Abstract]   [Full Text] [Related]  

  • 8. The risk of tramadol abuse and dependence: findings in two patients.
    Stoehr JD; Essary AC; Ou C; Ashby R; Sucher M
    JAAPA; 2009 Jul; 22(7):31-2, 34-5. PubMed ID: 19697569
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of opioid painkiller dependence in primary care: ongoing recovery with buprenorphine/naloxone.
    Hard B
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25432908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsule commentary on Turner et al., chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant results.
    Chiovaro J
    J Gen Intern Med; 2015 Feb; 30(2):241. PubMed ID: 25387440
    [No Abstract]   [Full Text] [Related]  

  • 11. Is buprenorphine-naloxone ready for prime time in the treatment of opioid addiction in managed care?
    Curtiss FR
    J Manag Care Pharm; 2008 Mar; 14(2):195-7. PubMed ID: 18331121
    [No Abstract]   [Full Text] [Related]  

  • 12. Office-based treatment of opiate addiction.
    Heit HA; Gourlay DL
    N Engl J Med; 2003 Dec; 349(26):2567-8; author reply 2567-8. PubMed ID: 14695422
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical treatments for opioid use disorder in Iran: a randomized, double-blind placebo-controlled comparison of buprenorphine/naloxone and naltrexone maintenance treatment.
    Mokri A; Chawarski MC; Taherinakhost H; Schottenfeld RS
    Addiction; 2016 May; 111(5):874-82. PubMed ID: 26639678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short answer question case series: the perils of urine toxicology testing.
    Graubard M; Rohdenberg P; Jang T
    Emerg Med J; 2011 Nov; 28(11):998-9. PubMed ID: 21708959
    [No Abstract]   [Full Text] [Related]  

  • 15. The changing face of opioid addiction: prescription pain pill dependence and treatment.
    Byrne MH; Lander L; Ferris M
    Health Soc Work; 2009 Feb; 34(1):53-6. PubMed ID: 19281102
    [No Abstract]   [Full Text] [Related]  

  • 16. The Rhode Island community responds to opioid overdose deaths.
    Bowman S; Engelman A; Koziol J; Mahoney L; Maxwell C; McKenzie M
    R I Med J (2013); 2014 Oct; 97(10):34-7. PubMed ID: 25271658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines.
    Balhara YP
    J Opioid Manag; 2013; 9(4):237. PubMed ID: 24380101
    [No Abstract]   [Full Text] [Related]  

  • 18. Controversies and carfentanil: We have much to learn about the present state of opioid poisoning.
    Cole JB; Nelson LS
    Am J Emerg Med; 2017 Nov; 35(11):1743-1745. PubMed ID: 28851500
    [No Abstract]   [Full Text] [Related]  

  • 19. Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.
    Cottrill CB; Matson SC
    Adolesc Med State Art Rev; 2014 Aug; 25(2):251-65. PubMed ID: 27132312
    [No Abstract]   [Full Text] [Related]  

  • 20. In brief: Buprenorphine/naloxone (Zubsolv) for opioid dependence.
    Med Lett Drugs Ther; 2013 Oct; 55(1427):83. PubMed ID: 24129113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.